Kymera Therapeutics (KYMR)'s 30-day implied volatility (IV30) was 126.1% at the close on November 3, 2026, up from 115.5% the day before, against a 52-week range of 40.1% to 147.4%. Its 20-day historical volatility was 51.2%.
Data as of November 3, 2026.